OTCM
ANSLY
Market cap3.10bUSD
Jul 09, Last price
84.09USD
1D
0.00%
1Q
0.67%
Jan 2017
18.14%
Name
Ansell Ltd
Chart & Performance
P/E
116.89
P/S
5.93
EPS
0.72
Div Yield, %
1.83%
Shrs. gr., 5y
2.02%
Rev. gr., 5y
4.42%
Revenues
2.00b
+23.71%
Net income
102m
+32.81%
CFO
239m
-12.12%
Dividend
Aug 30, 20240.876 USD/sh
Earnings
Aug 25, 2026
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Ansell Limited, an Australian company established in Richmond in 1893, is a global leader in the innovation, development, and production of protective equipment. Active across numerous regions including the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America, the company operates through two core divisions. It was previously known as Pacific Dunlop Limited, changing its name to Ansell Limited in 2002. P. D. Holdings Pty. Ltd. is a current subsidiary. Its Healthcare segment specializes in manufacturing and distributing a broad range of protective items such as surgical, examination, single-use, and sterile gloves, as well as specialized apparel and consumables. These products serve various medical and scientific settings, including hospitals, surgical facilities, dental practices, veterinary clinics, emergency services, laboratories, and pharmaceutical and life sciences organizations. The Industrial segment focuses on crafting and supplying protective solutions for hands and against chemical hazards. These products are essential for a diverse array of industrial applications, spanning automotive, chemical, metal fabrication, machinery and equipment, food processing, construction, mining, oil and gas, and first responder activities.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||